Known targets — ChEMBL curated mechanism
ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol
The experimentally established mechanism targets of Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alcohol SCHEMBL17183875 | 1.00 | TSHR (0.50) | — | |
| Alcohol SCHEMBL20295436 | 1.00 | TSHR (0.50) | — | |
| Alcohol SCHEMBL27681725 | 0.96 | — | — | |
| Alcohol SCHEMBL21924398 | 0.96 | TSHR (0.46) | — | |
| Alcohol SCHEMBL6384335 | 0.93 | ALDH1A1 (0.43) | — | |
| Sulfuric Acid SCHEMBL29518370 | 0.87 | TSHR (0.55) | — | |
| Sulfuric Acid SCHEMBL21624984 | 0.87 | TSHR (0.55) | — | |
| Dimethyl Sulfone SCHEMBL7886489 | 0.87 | — | — | |
| Sulfuric Acid SCHEMBL84046 | 0.87 | — | — | |
| Sulfuric Acid SCHEMBL9754869 | 0.87 | TSHR (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117166233-A | Ultra-light full-frequency-band PBO fiber wave-proof sleeve and preparation method and application thereof | 成都巨合新材料技术有限责任公司 | 2023-12-05 | — | — | CN | claimed |
| CN-112851506-B | Industrial preparation method of 3, 5-dimethoxy-4-alkyl benzyl alcohol | 湖北英纳氏生物科技有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-112851506-A | Industrial preparation method of 3, 5-dimethoxy, 4-alkyl benzyl alcohol | 湖北英纳氏生物科技有限公司 | 2021-05-28 | — | — | CN | claimed |
| CN-106336374-A | Method for preparing alfentanil and sufentanil and compound for preparing alfentanil and sufentanil | 江苏恩华药业股份有限公司 | 2017-01-18 | — | — | CN | claimed |
| US-20150175545-A1 | Preparation Method of Fluoro-Substituted Deuterated Diphenylurea | SUZHOU ZELGEN BIOPHARMACEUTICAL CO LTD (CN) | 2015-06-25 | — | — | US | claimed |
| CN-102803221-B | Deuterated omega-diphenylurea and derivative and pharmaceutical composition containing compound | SUZHOU ZELGEN BIOPHARMACEUTICAL CO LTD | 2014-09-10 | — | — | CN | claimed |
| CN-103113267-A | Method for preparing methanesulfonic acid from sodium methanesulfonate | JIANGSU JIXIAN GREEN CHEMISTRY SCIENCE & TECHNOLOGY RES INST CO LTD | 2013-05-22 | — | — | CN | claimed |
| CN-103030580-A | Preparation method of lapatinib intermediate | SHANDONG BOYUAN PHARMACEUTICAL CO LTD | 2013-04-10 | — | — | CN | claimed |
| EP-2562159-A1 | PREPARATION METHOD OF FLUORO-SUBSTITUTED DEUTERATED DIPHENYLUREA | Suzhou Zelgen Biopharmaceutical Co., Ltd. (CN) | 2013-02-27 | — | — | EP | claimed |
| EP-1511490-A4 | NOVEL CONAZOLE CRYSTALLINE FORMS AND RELATED PROCESSES, PHARMACEUTICAL COMPOSITIONS AND METHODS | TRANSFORM PHARMACEUTICALS INC (US) | 2009-03-11 | — | — | EP | claimed |
| US-20050070551-A1 | Novel crystalline forms of conazoles and methods of making and using the same | TRANSFORM PHARMACEUTICALS, INC. | 2005-03-31 | — | — | US | claimed |
| EP-1511490-A2 | NOVEL CONAZOLE CRYSTALLINE FORMS AND RELATED PROCESSES, PHARMACEUTICAL COMPOSITIONS AND METHODS | Transform Pharmaceuticals, Inc. (US) | 2005-03-09 | — | — | EP | claimed |
| US-20040019211-A1 | Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods | TRANSFORM PHARMACEUTICALS, INC. (US) | 2004-01-29 | — | — | US | claimed |
| WO-2003101392-A2 | NOVEL CONAZOLE CRYSTALLINE FORMS AND RELATED PROCESSES, PHARMACEUTICAL COMPOSITIONS AND METHODS | TRANSFORM PHARMACEUTICALS, INC. (US) | 2003-12-11 | — | — | WO | claimed |
| US-20260139068-A1 | ANTI-CD73 ANTIBODIES, CONJUGATES, AND METHODS OF USE | EISAI R&D MAN CO LTD (JP) | 2026-05-21 | — | — | US | disclosed |
| EP-3972649-B1 | MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | NOVARTIS AG (CH) | 2026-05-13 | — | — | EP | disclosed |
| US-20260061065-A1 | ANTIBODY DRUG CONJUGATES | NOVARTIS AG (CH) | 2026-03-05 | — | — | US | disclosed |
| CN-1092425-A | Indole derivatives, its manufacture method and medicinal use thereof | TORAY INDUSTRIES (JP) | 1994-09-21 | — | — | CN | disclosed |
| EP-0614898-A1 | INDOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL USE THEREOF | TORAY INDUSTRIES, INC. (JP) | 1994-09-14 | — | — | EP | disclosed |
| EP-0000306-A1 | Substituted hexahydrobenzopyrano(3,2-c)pyridines, process for their preparation and medicines containing them | LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) | 1979-01-10 | — | — | EP | disclosed |